In LAM, abnormal proliferation of smooth muscle-like cells and destruction of the lung parenchyma caused by TSC1 or TSC2 gene mutations increase the fragility of lung tissue and the risk of pneumothorax [27]. Here, TSC2 is linked to lymphangioleiomyomatosis.